203 related articles for article (PubMed ID: 12489282)
1. Cancer prevention in patients with inflammatory bowel disease.
Itzkowitz SH
Gastroenterol Clin North Am; 2002 Dec; 31(4):1133-44. PubMed ID: 12489282
[TBL] [Abstract][Full Text] [Related]
2. The histological diagnosis of dysplastic and neoplastic lesions in inflammatory bowel disease: a pathological perspective.
Usaj S; Tarabar D; Cuk V; Cerovic S; Brajukovic G; Panisic M; Klem I; Eric Z
Acta Chir Iugosl; 2004; 51(2):109-16. PubMed ID: 15771301
[TBL] [Abstract][Full Text] [Related]
3. Endoscopy/surveillance in inflammatory bowel disease.
Ahmadi AA; Polyak S
Surg Clin North Am; 2007 Jun; 87(3):743-62. PubMed ID: 17560423
[TBL] [Abstract][Full Text] [Related]
4. Cancer in inflammatory bowel disease.
Xie J; Itzkowitz SH
World J Gastroenterol; 2008 Jan; 14(3):378-89. PubMed ID: 18200660
[TBL] [Abstract][Full Text] [Related]
5. Colorectal Cancer Screening in Inflammatory Bowel Disease.
Sengupta N; Yee E; Feuerstein JD
Dig Dis Sci; 2016 Apr; 61(4):980-9. PubMed ID: 26646250
[TBL] [Abstract][Full Text] [Related]
6. Chemoprevention for colon cancer: new opportunities, fact or fiction?
Terhaar Sive Droste JS; Tuynman JB; Van Dullemen HM; Mulder CJ
Scand J Gastroenterol Suppl; 2006; (243):158-64. PubMed ID: 16782636
[TBL] [Abstract][Full Text] [Related]
7. Colorectal cancer surveillance in inflammatory bowel disease: Practice guidelines and recent developments.
Clarke WT; Feuerstein JD
World J Gastroenterol; 2019 Aug; 25(30):4148-4157. PubMed ID: 31435169
[TBL] [Abstract][Full Text] [Related]
8. Prevention of colorectal cancer in inflammatory bowel disease: value of screening and 5-aminosalicylates.
Munkholm P; Loftus EV; Reinacher-Schick A; Kornbluth A; Mittmann U; Esendal B
Digestion; 2006; 73(1):11-9. PubMed ID: 16410688
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and management of dysplasia in patients with inflammatory bowel diseases.
Itzkowitz SH; Harpaz N
Gastroenterology; 2004 May; 126(6):1634-48. PubMed ID: 15168373
[TBL] [Abstract][Full Text] [Related]
10. Dysplasia and cancer in inflammatory bowel disease.
Basseri RJ; Basseri B; Papadakis KA
Expert Rev Gastroenterol Hepatol; 2011 Feb; 5(1):59-66. PubMed ID: 21309672
[TBL] [Abstract][Full Text] [Related]
11. Chronic inflammatory bowel disease and cancer.
Pohl C; Hombach A; Kruis W
Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
[TBL] [Abstract][Full Text] [Related]
12. Chemoprevention of colorectal cancer in inflammatory bowel disease.
Ehrlich AC; Patel S; Meillier A; Rothstein RD; Friedenberg FK
Expert Rev Anticancer Ther; 2017 Mar; 17(3):247-255. PubMed ID: 28095263
[TBL] [Abstract][Full Text] [Related]
13. Colorectal cancer in inflammatory bowel disease: review of the evidence.
Keller DS; Windsor A; Cohen R; Chand M
Tech Coloproctol; 2019 Jan; 23(1):3-13. PubMed ID: 30701345
[TBL] [Abstract][Full Text] [Related]
14. [Colorectal cancer: screening and surveillance in inflammatory bowel diseases - consensus of the working group for inflammatory bowel diseases of the Austrian Society of Gastroenterology and Hepatology].
Angelberger S; Campregher C; Fuchssteiner H; Gasche C; Gröchenig HP; Haas T; Kazemi-Shirazi L; Mayer A; Miehsler W; Platzer R; Reinisch W; Steiner P; Tilg H; Tillinger W; Vogelsang H; Novacek G
Z Gastroenterol; 2013 May; 51(5):450-7. PubMed ID: 23681899
[TBL] [Abstract][Full Text] [Related]
15. Strategies for detecting colon cancer and dysplasia in patients with inflammatory bowel disease.
Collins PD
Inflamm Bowel Dis; 2013; 19(4):860-3. PubMed ID: 23446340
[TBL] [Abstract][Full Text] [Related]
16. Chemopreventive effects of 5-aminosalicylic acid on inflammatory bowel disease-associated colorectal cancer and dysplasia: a systematic review with meta-analysis.
Qiu X; Ma J; Wang K; Zhang H
Oncotarget; 2017 Jan; 8(1):1031-1045. PubMed ID: 27906680
[TBL] [Abstract][Full Text] [Related]
17. Cancer prevention in inflammatory bowel disease and the chemoprophylactic potential of 5-aminosalicylic acid.
Bernstein CN; Eaden J; Steinhart AH; Munkholm P; Gordon PH
Inflamm Bowel Dis; 2002 Sep; 8(5):356-61. PubMed ID: 12479651
[TBL] [Abstract][Full Text] [Related]
18. Chemoprevention: risk reduction with medical therapy of inflammatory bowel disease.
Chan EP; Lichtenstein GR
Gastroenterol Clin North Am; 2006 Sep; 35(3):675-712. PubMed ID: 16952746
[TBL] [Abstract][Full Text] [Related]
19. Chromoendoscopy for Dysplasia Surveillance in Inflammatory Bowel Disease.
Flynn AD; Valentine JF
Inflamm Bowel Dis; 2018 Jun; 24(7):1440-1452. PubMed ID: 29668929
[TBL] [Abstract][Full Text] [Related]
20. Patients' knowledge and fear of colorectal cancer risk in inflammatory bowel disease.
Lopez A; Collet-Fenetrier B; Belle A; Peyrin-Biroulet L
J Dig Dis; 2016 Jun; 17(6):383-91. PubMed ID: 27129893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
